AUGX stock icon

Augmedix
AUGX

$0.78
3.27%
 

About: Augmedix Inc is engaged in ambulatory/clinical/hospital segments of the U.S. patient care services market with products that address medical note documentation needs. The company's products cater to large and small healthcare organizations but can also be adopted by individual practitioners. The company products extract data from natural clinician-patient conversations and convert it in real time to medical notes, which are seamlessly transferred to the electronic health record (EHR). The company's revenues consist of service fees charged to its customers to subscribe to the company's remote medical documentation and clinical support products.

Employees: 1,430

0
Funds holding %
of 6,689 funds
0
Analysts bullish %
of 5 analysts
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

106% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 18

10% more call options, than puts

Call options by funds: $2.01M | Put options by funds: $1.82M

6.1% more ownership

Funds ownership: 75.1% [Q4 2023] → 81.19% (+6.1%) [Q1 2024]

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

1% less funds holding

Funds holding: 85 [Q4 2023] → 84 (-1) [Q1 2024]

23% less capital invested

Capital invested by funds: $209M [Q4 2023] → $162M (-$47.3M) [Q1 2024]

33% less funds holding in top 10

Funds holding in top 10: 3 [Q4 2023] → 2 (-1) [Q1 2024]

Research analyst outlook

5 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$3.5
351%
upside
Avg. target
$4.7
505%
upside
High target
$5.5
608%
upside

5 analyst ratings

positive
80%
neutral
20%
negative
0%
Lake Street
Brooks O'Neil
351%upside
$3.5
Buy
Maintained
14 May 2024
Evercore ISI Group
Elizabeth Anderson
544%upside
$5
Outperform
Upgraded
9 Apr 2024
B. Riley Securities
Neil Chatterji
608%upside
$5.5
Buy
Reinstated
3 Apr 2024
Evercore ISI Group
Elizabeth Anderson
480%upside
$4.5
In-Line
Maintained
19 Mar 2024
Maxim Group
Allen Klee
544%upside
$5
Buy
Maintained
19 Mar 2024

Financial journalist opinion